Sema4: (NASDAQ:WGS)
Sema4 (WGS) is scheduled to announce Q4 earnings results on Tuesday, March 14th, after market close.The consensus EPS Estimate is -$0.16 (+5.9% Y/Y) and the consensus Revenue Estimate...
Read full article »
Sema4 is a Connecticut-based health intelligence company that offers solutions such as genetic testing and data-driven insights for patients.
Read more